Seven vs Fourteen Days of Antibiotics for Gram-Negative Bloodstream Infection
Todd C. Lee(McGill University Health Centre), Nick Daneman(St. Joseph’s Healthcare Hamilton), Asgar Rishu(Western University), Dafna Yahav(Sheba Medical Center), Connor Prosty(McGill University), Elodie von Dach(University Hospital of Geneva), Mical Paul(Technion – Israel Institute of Technology), Ruxandra Pinto(Apple (Israel)), Michael Fralick(University Health Network), José Molina(Centre for Biomedical Network Research on Rare Diseases), Emily G. McDonald(McGill University Health Centre), Angela Huttner(University Hospital of Geneva), Rob Fowler(University of Toronto)
Cited by 24
Related Papers
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
|Clinical Microbiology and Infection|2021|1k
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
|Antimicrobial Agents and Chemotherapy|2010|727
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
|Annals of Internal Medicine|2020|548